WO2010018167A1 - Formulations dentaires destinées à la prévention de l’érosion dentaire - Google Patents
Formulations dentaires destinées à la prévention de l’érosion dentaire Download PDFInfo
- Publication number
- WO2010018167A1 WO2010018167A1 PCT/EP2009/060376 EP2009060376W WO2010018167A1 WO 2010018167 A1 WO2010018167 A1 WO 2010018167A1 EP 2009060376 W EP2009060376 W EP 2009060376W WO 2010018167 A1 WO2010018167 A1 WO 2010018167A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- care product
- dental care
- dental
- enamel
- fluoride
- Prior art date
Links
- 230000003628 erosive effect Effects 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title description 31
- 238000009472 formulation Methods 0.000 title description 6
- 230000002265 prevention Effects 0.000 title description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000004367 Lipase Substances 0.000 claims abstract description 13
- 102000004882 Lipase Human genes 0.000 claims abstract description 13
- 108090001060 Lipase Proteins 0.000 claims abstract description 13
- 235000019421 lipase Nutrition 0.000 claims abstract description 13
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 11
- 239000002563 ionic surfactant Substances 0.000 claims abstract description 8
- 101710118538 Protease Proteins 0.000 claims abstract description 6
- 239000000606 toothpaste Substances 0.000 claims description 60
- 229940034610 toothpaste Drugs 0.000 claims description 53
- 102000004139 alpha-Amylases Human genes 0.000 claims description 51
- 108090000637 alpha-Amylases Proteins 0.000 claims description 51
- 229940024171 alpha-amylase Drugs 0.000 claims description 47
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 26
- 229940088598 enzyme Drugs 0.000 claims description 26
- -1 alkaline earth metal salt Chemical class 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000002324 mouth wash Substances 0.000 claims description 12
- 229940051866 mouthwash Drugs 0.000 claims description 12
- 230000001680 brushing effect Effects 0.000 claims description 11
- 229940112822 chewing gum Drugs 0.000 claims description 11
- 235000015218 chewing gum Nutrition 0.000 claims description 11
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 235000003599 food sweetener Nutrition 0.000 claims description 9
- 239000003906 humectant Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000002736 nonionic surfactant Substances 0.000 claims description 9
- 239000003765 sweetening agent Substances 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 230000002538 fungal effect Effects 0.000 claims description 8
- 238000005498 polishing Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 239000007937 lozenge Substances 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- 244000153158 Ammi visnaga Species 0.000 claims description 5
- 235000010585 Ammi visnaga Nutrition 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000012459 cleaning agent Substances 0.000 claims description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 230000001055 chewing effect Effects 0.000 claims description 4
- 150000004673 fluoride salts Chemical class 0.000 claims description 4
- 229910001506 inorganic fluoride Inorganic materials 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000002087 whitening effect Effects 0.000 claims description 3
- 239000002253 acid Substances 0.000 abstract description 38
- 150000007513 acids Chemical class 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 6
- 210000004051 gastric juice Anatomy 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000003298 dental enamel Anatomy 0.000 description 102
- 239000000047 product Substances 0.000 description 75
- 210000003296 saliva Anatomy 0.000 description 58
- 235000018102 proteins Nutrition 0.000 description 55
- 102000004169 proteins and genes Human genes 0.000 description 55
- 108090000623 proteins and genes Proteins 0.000 description 55
- 230000001681 protective effect Effects 0.000 description 36
- 239000003599 detergent Substances 0.000 description 32
- 241000283690 Bos taurus Species 0.000 description 28
- 239000004141 Sodium laurylsulphate Substances 0.000 description 26
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 26
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 229940091249 fluoride supplement Drugs 0.000 description 24
- 102000013142 Amylases Human genes 0.000 description 19
- 108010065511 Amylases Proteins 0.000 description 19
- 235000019418 amylase Nutrition 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- 239000004382 Amylase Substances 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 208000002925 dental caries Diseases 0.000 description 14
- 230000002378 acidificating effect Effects 0.000 description 13
- 235000021277 colostrum Nutrition 0.000 description 13
- 210000003022 colostrum Anatomy 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 210000000214 mouth Anatomy 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 239000012530 fluid Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 238000005115 demineralization Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 235000014214 soft drink Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 6
- 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 6
- 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 210000004268 dentin Anatomy 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 5
- 239000004088 foaming agent Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000012676 herbal extract Substances 0.000 description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 239000011241 protective layer Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229940025131 amylases Drugs 0.000 description 4
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 4
- 229910001634 calcium fluoride Inorganic materials 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 239000005995 Aluminium silicate Substances 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003082 abrasive agent Substances 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 229910000323 aluminium silicate Inorganic materials 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000000593 degrading effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000194 fatty acid Chemical class 0.000 description 3
- 229930195729 fatty acid Chemical class 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 108010075550 termamyl Proteins 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 240000006439 Aspergillus oryzae Species 0.000 description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 210000001142 back Anatomy 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000005313 bioactive glass Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000001315 dental pellicle Anatomy 0.000 description 2
- 229940023487 dental product Drugs 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004283 incisor Anatomy 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 210000004373 mandible Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 235000015205 orange juice Nutrition 0.000 description 2
- 210000003681 parotid gland Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 235000020185 raw untreated milk Nutrition 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940080728 steareth-30 Drugs 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- RYJDNPSQBGFFSF-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;carbonic acid Chemical class OC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RYJDNPSQBGFFSF-WCCKRBBISA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical class CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102100033770 Alpha-amylase 1C Human genes 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001310324 Cetraria islandica Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010026386 Salivary alpha-Amylases Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 208000004188 Tooth Wear Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 229920006387 Vinylite Polymers 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical class [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229920003180 amino resin Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- OYLGJCQECKOTOL-UHFFFAOYSA-L barium fluoride Chemical compound [F-].[F-].[Ba+2] OYLGJCQECKOTOL-UHFFFAOYSA-L 0.000 description 1
- 229910001632 barium fluoride Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- DGTVXEHQMSJRPE-UHFFFAOYSA-N difluorophosphinic acid Chemical compound OP(F)(F)=O DGTVXEHQMSJRPE-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229940104869 fluorosilicate Drugs 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000020604 functional milk Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 230000007775 late Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000013580 millipore water Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- KZNNRLXBDAAMDZ-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane trihydrate Chemical compound O.O.O.O=[Al]O[Al]=O KZNNRLXBDAAMDZ-UHFFFAOYSA-N 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229920001277 pectin Chemical class 0.000 description 1
- 239000001814 pectin Chemical class 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000271 synthetic detergent Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Definitions
- the invention relates to the provision of a dental care product for preventing and/or inhibiting dental erosion in a mammalian subject that typically arises as a result of repeated exposure of tooth surfaces to acids, which may originate from food, drinks, or gastric juice.
- Dental erosion is chemical wear of teeth without involvement of bacteria (Eccles, 1979). This condition can cause a progressive loss of dental hard tissue (enamel or dentine) and is often characterised by being evenly distributed over the whole surface of the involved teeth.
- Dental erosion develops after repeated exposure of tooth surfaces to acids, which may originate from food, drinks, or gastric juice.
- dental caries is caused by acid producing bacterial deposits on poorly cleaned areas on tooth surfaces. Therefore dental caries result in much more localised loss of enamel or dentine that may develop into cavities and tooth decay, which need dental treatment in the form of fillings or crowns.
- Soft drink consumption seems to be the most common source of acid for dental erosion (Jensdottir et al., 2004).
- tooth brushing will not prevent dental erosion.
- tooth brushing may accelerate dental erosion if performed shortly after intake of acidic foodstuffs (Attin et al., 2001 ).
- acidic foodstuffs Attin et al., 2001 .
- the combination of mechanical forces from toothbrushing working together with the chemical weakening of the tooth surface caused by acidic foodstuffs strongly accelerates the loss of tooth substance and results in increased dental wear compared to either of the two processes alone.
- If toothbrushing is performed before the intake of acidic foodstuffs it may also influence the development of dental erosion.
- In vivo tooth surfaces that are not brushed will normally become covered in a layer of bacteria also known as dental plaque, which may act as protection against acid from foodstuffs.
- toothpaste often contains detergents, which may expose or prime the inorganic components of the teeth to acid demineralisation (Rykke et al., 1990). Accordingly, toothbrushing makes teeth become more susceptible to acids from foodstuffs and soft drinks.
- EP1568356A1 describes the use of colostrum protein in a dental care product to prevent dental erosion.
- WO2006/016803 describes the use of a functional milk fraction in a dental care product to prevent dental erosion where the protective activity is attributed to a low molecular weight nitrogen fraction of milk or whey, being neither lactose nor the mineral fraction.
- WO2005/110347 describes the use of hydrofluoric acid at concentrations of 0.05-2.00% at a pH of 2.5-4.5 in a dental care product to prevent dental erosion.
- the long-term effects and the clinical significance of adding such erosion-preventing substances to dentifrice are, however, still largely unknown.
- the claimed the invention relates to the use of a starch-degrading enzyme of E. C. 3.2.1.1 for the manufacture of a dental care product for preventing and/or inhibiting dental erosion, wherein said product comprises less than 1 % ionic surfactant by weight.
- the product is substantially free of endoprotease and optionally is also substantially free of lipase.
- the dental care product is a toothpaste, tooth gel, tooth powder, denture cleaning agent, mouthwash, lozenge or chewing gum.
- the dental care product is dental floss or a toothpick.
- starch- hydrolyzing enzyme is alpha-amylase ( ⁇ -amylase) of bacterial or fungal origin.
- the starch-hydrolyzing enzyme comprises from 0.1 % to 20% weight by weight of the dental care product.
- the dental care product further comprises one or more of an abrasive polishing material, whitening agent, flavoring agent, humectant, binder, thickener, and/or sweetener.
- the dental care product further comprises one or more fluoride-ion releasing agent that is an inorganic fluoride salt selected from a soluble alkali metal and an alkaline earth metal salt.
- the dental care product further comprises one or more fluoride-ion releasing agent in an amount sufficient to release 300 to 2,000 ppm of fluoride ions by weight of the dental care product.
- the dental care product further comprises zinc ions in an amount in the range of 0.0025 - 0.15 % by weight of the dental care product
- the dental care product further comprises a non-ionic surfactant in an amount not exceeding 15% by weight of the dental care product.
- the claimed invention further relates to a dental care product for preventing and/or inhibiting dental erosion comprising a starch-degrading enzyme of E. C. 3.2.1.1 , wherein said product comprises less than 1 % ionic surfactant by weight.
- a dental care product for preventing and/or inhibiting dental erosion comprising a starch-degrading enzyme of E. C. 3.2.1.1 , wherein said product comprises less than 1 % ionic surfactant by weight.
- the product is substantially free of endoprotease and optionally is also substantially free of lipase.
- said dental care product is a toothpaste, tooth gel, tooth powder, denture cleaning agent mouthwash, lozenge or chewing gum.
- said dental care product is dental floss or a toothpick.
- the starch- hydrolyzing enzyme is alpha-amylase of bacterial or fungal origin.
- the claimed invention further relates a method of preventing and/or inhibiting dental erosion in a mammalian subject, comprising the steps of: (a) contacting the dental care product of the invention with the teeth and/or gums of the subject for between about 30 seconds to 15 minutes; wherein said contact is combined with brushing, chewing and/or rinsing.
- Figure 1 Changes in surface microhardness values (SMH) of sound and healthy polished bovine enamel blocks (1 cm 2 ) after 30 minutes of exposure to 50 ml_ of Type I water containing the anionic detergent SLS at concentrations ranging between 1 and 5 percent (w/v).
- Figure 2. Protective effect against acid-induced enamel softening of pellicles developed from solutions of 0.5% w/v human whole saliva proteins (saliva) on bovine enamel.
- the present invention seeks to prevent or inhibit the process of dental erosion and thereby preserve dental hard tissue in the oral cavity of a subject.
- the human salivary ⁇ -amylase when incorporated into a dental pellicle on an enamel surface, is able to protect the enamel against demineralisation during an acid exposure.
- bovine enamel that was coated with parotid saliva having a high ⁇ -amylase concentration was able to maintain its surface microhardness better than enamel that was coated with saliva samples having a lower amylase concentration.
- ⁇ -amylase was the only protein whose abundance could be directly related to the protective effect of the samples against an acid exposure. Therefore ⁇ - amylase in a dental care product can be used for prevention and/or inhibition of the process of dental erosion.
- industrially produced ⁇ -amylases of bacterial, as well as fungal origin posses the same ability to coat and protect enamel surfaces against the demineralisation that occurs during an acid exposure. Therefore, a toothpaste containing ⁇ -amylase can protect the teeth better than regular toothpaste without amylase (Figure 5).
- amylase when provided in a dental composition, binds to the surface of teeth contributing to the creation and maintenance of a protective protein layer on their surfaces. In this manner the natural protein layer on the surface of teeth, i.e. the pellicle, is restored and preserved.
- Amylase in the dental care product of the invention, not only contributes to the preservation of the pellicle, but also catalyses the degradation of starch in food debris present in the oral cavity and deposited on the tooth surface.
- a dental care product comprising amylase, acts together with salivary amylases as a natural detergent in the oral cavity, by selectively degrading starch while leaving the protective protein layer intact on the surface of the teeth after dental care e.g. brushing.
- the dental care products of the invention largely eliminate the need for strong anionic detergents (e.g. sodium lauryl sulphate; SLS), in toothpaste, which are otherwise employed to clean teeth and the oral cavity.
- strong anionic detergents serve to strip off food debris.
- strong anionic detergents have the capacity to make the enamel surface vulnerable to acid erosion by interfering with the formation of the protective pellicle and thereby increasing the vulnerability of the tooth surface following tooth brushing.
- ionic detergents particularly anionic detergents
- the dental care products of the invention serves to avoid or greatly minimise binding of calcium ions and the loss and inhibition of renewal of the protein protective layer, and thereby protects teeth from the erosive effects of acid exposure.
- Enzymes such as endoproteases and/or lipases, which may interfere with the formation of the protective pellicle, by degrading proteins and/or lipoproteins in this protective layer, are preferably to be avoided.
- the invention serves to provide the tooth surface after tooth brushing with a protein layer protection comparable to the protection it had before tooth brushing.
- dental erosion is the process whereby dental hard tissue (i.e. enamel and dentine) is eroded by acids that are not produced by bacteria in the dental plaque.
- Dental erosion can be specifically measured by clinical examination of teeth, comparison of plaster or acrylic dental casts of the same teeth made at different time points, profilometric scanning of tooth surfaces, microradiography, and loss of minerals from tooth surfaces exposed to eroding fluids.
- the erosive potential or effect of different fluids can also be determined indirectly as changes in surface microhardness of enamel or dentine by the Knoop or Vickers microhardness tests [Hannig et al., 2004].
- dental caries is the process whereby dental hard tissue (i.e. enamel and dentine) is demineralised, and eventually decayed due to caries lesion formation, by acids that are produced by bacteria in the dental plaque.
- Dental caries can be specifically measured by visual examination of teeth including air-drying and probing, by x-ray examination, by microradiography, by colorimetric methods that include colouring of decayed dentine, by various photometric methods including quantitative fluorescence (QLF) and polarised light, and by electrical methods (electrical caries measurement - ECM).
- dental erosion leads to loss of dental hard tissue over large areas of the surfaces of teeth due to acid induced erosion; while dental caries is characterised by a localised loss of dental hard tissue from a tooth due to bacterial induced demineralisation detectable as localised pits or cavities in the tooth surface.
- the invention provides a dental care composition that comprises at least one starch-hydrolysing enzyme in an amount sufficient to prevent dental erosion, but comprises less than 1 wt.% (more preferably between 0 and 0.5 wt.%) ionic detergents.
- the product is substantially free of ionic detergents and the enzymes: (endo)proteases and/or lipases.
- the dental composition and the dental care product may contain fluoride and antimicrobial agents for prevention of demineralisation, enhancement of remineralisation and to control bacterial growth.
- starch-hydrolysing enzyme in the context of the present application refers to the enzyme, ⁇ -amylase (E. C. 3.2.1.1 ), which functions to hydrolyse linkages in starch.
- the ⁇ -amylase may be a bacterial ⁇ - amylase, such as BANTM or MaltogenaseTM (both available from Novo Nordisk), or an ⁇ -amylase derived from Bacillus subtilis; an ⁇ -amylase derived from Bacillus amyloliquefaciens; an ⁇ -amylase derived from Bacillus stearothermophilus; an ⁇ -amylase derived from Aspergillus oryzae; or an ⁇ -amylase derived from a non-pathogenic microorganism.
- the ⁇ -amylase may also be a fungal ⁇ -amylase, such as FungamylTM, which is available from Novo Nordisk.
- ionic surfactant or "ionic detergent” in the context of the present application comprise both: An ionic-detergents or anionic-surfactants (including soap and the largest portion of modern synthetic detergents), which produce electrically negative colloidal ions in solution; and cationic- detergents or cationic-detergents, containing a long-chain cation, which produce electrically positive ions in solution.
- protease enzyme that attacks and cleaves internal peptide bonds of a protein (e.g. trypsin, chymotrypsin, pepsin, papain, elastase).
- lipase in the context of the present application means: a water- soluble enzyme that catalyzes the hydrolysis of ester bonds in water- insoluble, lipid substrates, and for example act to convert triglyceride substrates found in oils from food to monoglycerides and free fatty acids.
- the invention further provides a "dental care product” comprising the dental care composition of the invention.
- a "dental care product” is defined as a product, which can be used for preventing or inhibiting dental erosion, which also serves to maintain and/or improve oral hygiene in the mouth of a human and animal subject, and/or preventing or inhibiting dental caries.
- the amount of starch-hydrolysing enzyme in the dental composition depends on the "dental care product" to be prepared.
- a dental composition and the dental care product will contain said enzyme in an amount that lies within the range of from 0.0001 wt.% to 20 wt.%, preferably from 0.1 wt.% to 5 wt.%, more preferably from 1 wt.% to 3 wt.%
- both the dental composition and the dental care product comprise less than 1 % (more preferably between 0 and 0.5%) ionic detergents, and are preferably substantially free of (endo)proteases and/or lipases.
- dental care products of the invention include a toothpaste, dental cream, gel or tooth powder, odontic, mouthwash, denture-cleaning agent, pre- or post-brushing rinse formulation, chewing gum and lozenge.
- a dental care product may also be in the form of a dental floss or toothpick.
- further components of the product typically include one or more of an abrasive or polishing material, whitening agent, antibacterial protein, foaming agent, flavouring agent, humectant, binder, thickener, sweetener, neutralising agent, herbal extracts or the like, remineralising compounds, and water.
- further components typically comprise one or more of a water/alcohol solution, a flavouring agent, humectant, sweetener, foaming agent, herbal extracts or the like, remineralising compounds, and colorant.
- the product may be prepared by incorporating one or more starch-hydrolysing enzyme into a conventional chewing gum base, e.g. jelutone, rubber lates, vinylite resins preferably in combination with conventional plasticisers or softeners, natural and/or artificial sweeteners, flavourings, etc. as desired.
- a conventional chewing gum base e.g. jelutone, rubber lates, vinylite resins preferably in combination with conventional plasticisers or softeners, natural and/or artificial sweeteners, flavourings, etc.
- Preparation of the chewing gum may involve stirring any of the components of the chewing gum formulation into a warm gum base, or coating the outer surface of the gum base.
- the temperature of the gum base should preferably not exceed 60° C, more preferably not exceed 50° C.
- Toothpaste of the invention may be substantially solid or pasty and comprise one or more of an abrasive or polishing material such as: alumina and hydrates thereof, such as alpha alumina trihydrate; magnesium trisilicate, magnesium carbonate; sodium bicarbonate ("baking soda"); kaolin; aluminosilicates, such as calcined aluminium silicate and aluminium silicate; calcium carbonate; zirconium silicate; silica xerogels, hydrogels and aerogels and the like.
- an abrasive or polishing material such as: alumina and hydrates thereof, such as alpha alumina trihydrate; magnesium trisilicate, magnesium carbonate; sodium bicarbonate ("baking soda”); kaolin; aluminosilicates, such as calcined aluminium silicate and aluminium silicate; calcium carbonate; zirconium silicate; silica xerogels, hydrogels and aerogels and the like.
- polishing materials include silica gel or colloidal silica having particle sizes between 1 and 20 microns, preferably between 1 and 10 microns.
- Additional polishing agents may include powdered synthetic plastic materials such as polyvinyl fluoride, polyvinyl chloride, polyamides, polymethyl methacrylate, epoxy resins, powdered polyethylene, polystyrene, phenol-formaldehyde resins, aminoplasts such as urea- or melamine-formaldehyde-condensates (having a particle size of between about 0.5 and about 40 microns, preferably between about 1 and about 20 microns). Additional polishing agents may also include bioactive glass such as NovaMin® that could add to the erosion protecting effects of the toothpaste.
- powdered synthetic plastic materials such as polyvinyl fluoride, polyvinyl chloride, polyamides, polymethyl methacrylate, epoxy resins, powdered polyethylene, polystyrene, phenol-formaldehyde resins, aminoplasts such as urea- or melamine-formaldehyde-condensates (having a particle size of between about 0.5
- the abrasive material content typically lies in the range from 10% to 75% by weight when the final dental product is toothpaste; and from 70% to 99% by weight, when it is a tooth powder.
- the liquid vehicle may comprise water and a humectant, which is employed to prevent loss of water.
- Suitable humectants for use in a dental care product according to the invention include one or more of: glycerol, polyol, sorbitol, polyethylene glycols (PEG), propylene glycol, 1 ,3- propanediol, 1 ,4-butane-diol, and hydrogenated partially hydrolysed polysaccharides.
- Humectants are in general present in an amount of from 0% to 80%, preferably 5 to 70% by weight in toothpaste.
- suitable thickeners and binders which help stabilize the dental care product are silica, starch, tragacanth gum, xanthan gum, extracts of Irish moss, alginates, pectin, cellulose derivatives, such as hydroxyethyl cellulose, sodium carboxymethyl cellulose and hydroxy- propyl methyl cellulose, hydroxy-butyl methyl cellulose, polyacrylic acid and its salts, and polyvinyl-pyrrolidone.
- Thickeners may be present in toothpastes and gels in an amount of from 0.1 to 20% by weight, and binders in an amount of from 0.01 to 10% by weight of the final product.
- Suitable sweeteners for use in dental care products of the invention include lactose, maltose, sorbitol, xylitol, sodium cyclamate, perillartine, APM (aspartyl phenyl alanine methylester) saccharin and/or other sweeteners.
- Suitable flavouring agents for use in dental care products of the invention are oils, including oil of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, majoram, cinnamon, lemon and orange. These sweeteners and flavouring agents may together comprise from 0.01 % to about 5% by weight, especially from 0.1 % to 5% of a dental care product.
- Suitable foaming agents for use in dental care products of the invention are limited to surfactants (detergents) that do not significantly solubilise the protein protective layer of the teeth, and also do not exert any adverse effect on the activity of the starch-degrading enzyme in the dental composition.
- suitable surfactants are limited to non-ionic surfactants, including fatty alcohol sulphates, salts of sulphonated monoglycerides or fatty acids having from 10 to 20 carbon atoms, fatty acid-albumin condensation products, salts of fatty acids amides and taurines and/or salts of fatty acid esters of isethionic acid.
- the amount of the non-ionic surfactant should not exceed from 15% by weight, more preferably 5% by weight, of the final dental care product.
- Suitable neutralizing agents used to maintain a pH in the range of 4.5 to 10, preferably in the range of 5.5 to 8 in the dental care product of the invention, include sodium bicarbonate, citrate, benzoate, carbonate, disodium hydrogen phosphate, or sodium dihydrogen phosphate.
- Water is usually added to a dental care product in an amount giving e.g. a toothpaste in a flow-able form, i.e. an amount of from 40% to 70% by weight of the final product.
- the dental care product of the invention may further include the addition of anti-calculus agents such as pyrophosphates and phosphonates; anti- plaque agents such as triclosan, chlorhexidine, bromochlorophene and sanquinarine; antibacterial proteins such as lanthibiotics (e.g. nisin); teeth de-sensitizing agents such as strontium salts and/or potassium nitrate or citrate; wound-healing agents such as allantoin, chlorophyll, tocopherol.
- anti-calculus agents such as pyrophosphates and phosphonates
- anti- plaque agents such as triclosan, chlorhexidine, bromochlorophene and sanquinarine
- antibacterial proteins such as lanthibiotics (e.g. nisin)
- teeth de-sensitizing agents such as strontium salts and/or potassium nitrate or citrate
- wound-healing agents such as allanto
- water-soluble anti-bacterial agents may also be included in the dental care product, such as chlorhexidine digluconate, hexetidine, alexidine, quaternary ammonium anti-bacterial compounds; and water- soluble sources of certain metal ions such as zinc, copper, silver and stannous ions (e.g. zinc, copper and stannous chloride, and silver nitrate).
- water-soluble anti-bacterial agents such as chlorhexidine digluconate, hexetidine, alexidine, quaternary ammonium anti-bacterial compounds; and water- soluble sources of certain metal ions such as zinc, copper, silver and stannous ions (e.g. zinc, copper and stannous chloride, and silver nitrate).
- the presence of one or more fluoride ion-producing agent in the dental care product is particularly preferred as anti-caries agents.
- Suitable compounds yielding fluoride ions are inorganic fluoride salts, such as soluble alkali metal and alkaline earth metals salt
- the amount of fluoride ion-providing compounds in the dental care product is dependent upon the type of compound, its solubility, and the type of dental care product, but generally the amount lies from 0.005 to 3.0 wt.% in the final product, said amount releasing up to about 5,000 ppm fluoride ions by weight of the dental care product.
- the amount of fluoride ion-providing compound is sufficient to release about 300 to 2,000 ppm, more preferably 800 to 1 ,500 ppm of fluoride ions.
- alkali metal fluorides in an amount of up to 2 wt.%, more preferably between 0.05-1 wt.% in the dental care product; and in the case of sodium mono-fluorophosphate in an amount of 0.1-3 wt.%.
- the fluoride ion-providing compound is typically present in an amount sufficient to release about 500 ppm, preferably 25 to 300 ppm by weight of fluoride ions, corresponding to about 0.005 to 1.0 wt.% of such compound in the dental care product. Determination of fluoride levels in the oral hygiene product, as well as the resulting increase in salivary fluoride levels, can be determined with fluoride sensitive electrodes as described by Bruun et al. (1984).
- the dental care product of the invention may contain zinc ions, generally in the form of a salt.
- Orally-acceptable anions with which zinc ions form a salt include: fluoride, fluorosilicate, monofluorophosphate, chloride, citrate, gluconate, thiocyanate, sulphate, acetate.
- the amount of zinc ions as Zn in a dental care product of the invention is in the range of 0.0025 - 0.15 wt.%, preferably from 0.01 to 0.1 wt.%, more preferably from 0.025 to 0.05 wt.%.
- the corresponding weight % of the zinc salt will be greater determined by the molecular weight of the anion in the salt.
- the toothpaste may also contain various natural organic and inorganic ingredients from plants, herbs and salts that may have possible beneficial effects in the oral environment, mostly anti-bacterial. These may include herbs and herbal extracts such as Aloe Vera, various sorts of tea products including Green Tea, liquorice and extracts of liquorice, cocoa and extracts of cocoa, Iceland moss, and similar ingredients. In formulations low in fluoride the toothpaste may also contain various compounds with remineralising effects adding to the erosion protecting effect of the toothpaste. Such compounds may include amorphous calcium phosphate (ACP), casein phosphopeptide (CCP), arginine- bicarbonate/calcium-carbonate complexes (SensiStat®), bioactive glass (NovaMin®), and nano-hydroxyapatite.
- the remineralising content typically lies in the range from 0 to 10% by weight when the final dental product is toothpaste; preferably from 0 to 5% by weight.
- a toothpaste produced from an dental care composition of the invention may e.g. comprise the following ingredients (in weight % of the final toothpaste composition):
- composition 10% to 70% abrasive material; 0 to 80% humectant; 0.1 % to 20% thickener; 0.01 % to 10% binder; 0.1 % to 5% sweetener; 0 to 15% foaming agent (non-ionic surfactant); 0.0001 % to 20% starch-degrading enzyme(s); 0 to 5% herbal extract(s) or other natural compounds with anti-bacterial effects, 0 to 1 % peroxide, and 0 to 5% remineralising compounds, wherein the product comprises less than 1 % ionic surfactant(s) (detergent) (preferably between 0 and 0.5%) and is substantially free of both (endo)protease(s) and lipase(s).
- the composition may be brought to 100% by the addition of water.
- a mouthwash produced from an dental care composition of the invention may e.g. comprise the following ingredients (in weight % of the final mouthwash):
- the mouthwash comprises less than 1 % (more preferably between 0 and 0.5%) ionic surfactant(s) (detergent), and is substantially free of both (endo)protease(s) and lipase(s).
- the mouthwash may be buffered with an appropriate buffer, e.g. sodium citrate or phosphate in the pH-range 6-7.5, and may be brought to 100% by the addition of water.
- the mouthwash may be in non-diluted form (i.e. to be diluted before use) or in diluted (ready-to-use) form.
- the dental care compositions and products of the present invention can be made using methods, which are common in the oral product field.
- the invention further relates to the use of one or more starch-hydrolysing enzymes as described above for the preparation of a composition for the prevention/inhibition of dental erosion.
- a dental care product in solid to flow-able form such as toothpaste, when used for oral cavity treatment, will typically be contacted with the teeth and/or gums using a toothbrush or the like; while a chewing gum or lozenge will be brought in contact with teeth and/or gums by chewing.
- a dental care product such as a mouthwash
- the contact will typically take place by rinsing the mouth.
- the time period during which a dental care product according to the invention is contacted with the teeth and/or gums to obtain the desired effect of preventing/inhibiting dental erosion can vary according to such factors as the nature of the composition or product and the need of the subject. However, contacting the dental care product with the teeth and/or gums for between about 30 seconds to 15 minutes will normally be sufficient for obtaining the desired result, e.g. contact by brushing the teeth or rinsing the mouth for a period of about 1 -3 minutes at a time. This is preferably performed on a regular basis, e.g. 1 -3 times a day.
- the dental care product is typically removed from the mouth, e.g. by spitting it out, and the mouth may subsequently be rinsed with a liquid such as tap water.
- the source of tooth enamel for all experiments described below was from bovine incisors (obtained from mandibles of 36 months old cattle collected at a slaughterhouse). The teeth were extracted from the mandible using standard dental equipment and the teeth were cleaned free of organic debris with a toothbrush in tap water. Crowns were divided from their roots and sectioned in buccal and lingual blocks using a water-cooled saw.
- the enamel blocks After being approved for inclusion in the study the enamel blocks they were kept moist at all times, and stored in a fluid, which was saturated with respect to hydroxyapatite (0.4 mM aqueous calcium hydrogen phosphate solution adjusted to pH 6.0 or the clarified supernatant of Type I water exposed to hydroxyapatite crystals in excess for 1 month) in order to avoid demineralisation or re- mineralisation.
- hydroxyapatite 0.4 mM aqueous calcium hydrogen phosphate solution adjusted to pH 6.0 or the clarified supernatant of Type I water exposed to hydroxyapatite crystals in excess for 1 month
- Each enamel block was stored in a small amount of this fluid ( ⁇ 1 ml_) in a glass container at around 5 0 C to maintain a moist environment around the enamel until used.
- bovine tissue has comparable demineralisation and re- mineralisation characteristics (Featherstone and Mellburg, 1981 ).
- the advantage of bovine enamel is that it can be obtained in large quantities from animals that have lived under relatively similar conditions.
- permanent bovine incisors from cattle that are about 36 months old could be obtained from slaughterhouses for the experiments.
- Microhardness of the enamel surface of a tooth provides a quantitative measure of the hardness of the enamel surface, and changes in hardness are directly correlated with the process and amount of dental erosion.
- SMH enamel surface microhardness
- Human parotid saliva proteins were derived from human parotid saliva, which was collected directly, from both parotid glands simultaneously, from subjects by taste stimulation with a continuous flow of orange juice at the dorsum of the tongue (around 15 ml/min) to stimulate saliva production. Following collection, the saliva was dialysed with a membrane having a molecular weight cut off of 1 kDa to obtain a protein enriched fraction, which was lyophilised, and dissolved in Type I water at a concentration of 0.5% w/v.
- Human whole saliva proteins were derived from whole saliva obtained from more than 100 young and healthy subjects stimulated by paraffin chewing, and the protein fraction was dialysed in a similar manner as the parotid saliva, where the lyophilised protein fraction was dissolved in Type I water at a concentration of 0.5% w/v.
- Bovine colostrum protein was derived from raw milk obtained from cows within 12 hours of having calved. Excess fat was removed from the colostrum by ether extraction, whereafter the de-fatted colostrum was dialysed, lyophilised and dissolved in Type I water at a concentration of 0.5% w/v.
- Each of the above protein preparations was dissolved (saliva proteins and colostrum) or diluted (industrially-produced amylases) in Type I water at a concentration of 0.5% w/v and used directly for coating enamel to form a pellicle in the following examples.
- the effect of drinking acidic soft drinks on dental enamel was simulated by exposing the enamel surface to an excess amount of an eroding fluid for a period of four minutes at room temperature.
- the eroding fluid with a volume of 2 litres contained 2% tartaric acid buffered to pH of 2.3 with 5 mmol/L calcium hydrogen phosphate.
- This fluid is employed to simulate a highly acidic soft drink as for example Coca Cola.
- the addition of calcium hydrogen phosphate was to promote softening of the enamel rather than direct erosion (surface loss), where the latter is not measurable as changes in surface microhardness.
- the enamel blocks were kept in HAp-saturated Type I water until SMH determinations were carried out at 3 locations on the surface of each enamel block within no more than 30 min.
- enamel blocks were placed in 10 ml_ test tubes and coated with 3 ml_ of Type I water containing 0.5% (w/v) of the proteins.
- the test tubes were mounted on a shaker so that the enamel was submersed in the protein solution for 15 seconds and then removed from the solution for another 15 seconds while within the test tubes.
- This setup was chosen, instead of simple immersion into the protein solutions, in order to simulate the cyclic flow of fluids in the oral cavity.
- Example 1 The effect of an anionic detergent on dental erosion
- the experiment was performed to test the effect of exposure to sodium lauryl sulphate (SLS), at concentrations ranging between 1 and 5 percent (w/v) SLS, on the Surface MicroHardness [SMH] of dental enamel surfaces.
- SLS sodium lauryl sulphate
- SMH Surface MicroHardness
- SLS surface microhardness
- Example 2 The effect of an anionic detergent on the protective capacity of salivary pellicles against acid-induced enamel softening of bovine enamel surfaces.
- the sample was divided into four groups, and subjected to a pre-treatment of either: water only; coating with human whole saliva proteins alone; immersion in 3 ml of 2 percent (w/v) SLS in Type 1 water for 10 minutes followed by coating with human whole saliva proteins; or coating with human whole saliva proteins followed by immersion in 3 ml of 2 percent (w/v) SLS in Type 1 water.
- Coating with saliva proteins, comprising a 0.5% solution of human whole saliva proteins (w/v) for 30 minutes was performed as described above [section 1.5], which creates a protective layer of saliva proteins (or pellicle) on the surface of the enamel.
- the pre-treated samples were then immediately subjected to exposure to acid solution [2% tartaric acid buffered to pH of 2.3 with 5 mmol/L calcium hydrogen phosphate] for 4 minutes as described above [section 1.3].
- the SMH of the treated enamel surfaces of each of the 4 samples was measured again, as described above.
- the mean SMH of the freshly polished enamel was 331 kp/mm 2
- the SMH of enamel pre-treated with water and then exposed to acid was 140 kp/mm 2 , giving a loss of SMH for uncoated enamel of 193 kp/mm 2 .
- the protective effect of the different pre-treaments on the enamel blocks following exposure to acid was calculated with respect to the loss in SMH measured for the enamel pretreated with water.
- a drop in SMH of 193 kp/mm 2 was set to equal 0% protection
- no drop in SMH was set to equal 100% protection.
- the protective effect of pellicles formed from coating with whole saliva proteins was 27 ⁇ 5% (Saliva only).
- the capacity of pellicles to protect bovine enamel against acid exposure was reduced when the enamel surface had been treated with a 2% SLS solution prior to pellicle formation with human salivary proteins as compared to untreated enamel surfaces having pellicles (p ⁇ 0.05) giving rise to a reduced protective effect of 23 ⁇ 6%. It is thought, that binding of SLS to the hydroxyapatite hydration shells in the enamel causes a change in the surface net-charge towards neutral, and thereby alters the initial development of the pellicle causing less protein to be absorbed on the enamel, resulting in reduced protection against acid.
- Figure 2 shows that if enamel, coated with a pellicle of human salivary proteins, is subsequently exposed to SLS, this significantly reduces the protective effect of the pellicle towards acid treatment (p ⁇ 0.01 ) giving rise to a further reduced protective effect of 21 ⁇ 5%. Accordingly, anionic detergents like SLS may interact negatively with the formation of the protective pellicle from salivary proteins on the enamel surfaces and reduce the protective effect of already formed pellicles.
- Example 3 The effect of ⁇ -amylase levels in human parotid saliva on its protective capacity as a pellicle against acid-induced enamel softening of saliva-coated bovine enamel surfaces.
- Saliva is a complex protein solution normally found in the oral cavity, which contains ⁇ -amylase. Healthy individuals were selected as a source of parotid saliva, which comprises a mixture of human parotid saliva proteins. Parotid saliva was collected directly, from both parotid glands simultaneously, from each of twenty subjects in total including thirteen males (23 ⁇ 1 yr) and seven females (22 ⁇ 1 yr) by taste stimulation with a continuous flow of orange juice at the dorsum of the tongue (around 15 ml/min) to produce as much saliva as possible.
- the saliva was dialysed with a membrane having a molecular weight cut off of 1 kDa to obtain a protein enriched fraction, which was lyophilised, and dissolved in Type I water at fixed concentration of 0.5% w/v for all twenty samples. All other techniques including preparation of enamel blocks, determination of enamel surface microhardness, and determination of protective effects were performed as described in Example 2. After the protective effect (% protection) of each parotid saliva sample was determined, the total protein composition in the saliva from each of the twenty individuals was determined by high-performance liquid chromatography (HPLC). Low molecular weight proteins were separated using a BDS C18 HPLC column, after precipitation and removal of amylase and mucin with phosphoric acid, and detected at 214 and 280 nm.
- HPLC high-performance liquid chromatography
- bovine enamel that was coated with parotid saliva having a high ⁇ - amylase concentration was able to maintain its surface microhardness better than enamel that was coated with saliva samples having a lower ⁇ - amylase concentration. Accordingly, ⁇ -amylase has the capacity to coat and protect enamel surfaces when present in a multicomponent system like saliva.
- Example 4 A comparison of the protective capacity of pellicles formed from different amylase preparations against acid-induced enamel softening of bovine enamel surfaces
- the industrially-produced amylases BAN, Fungamyl, Liquozyme, and Termamyl were obtained from NOVOZYMES.
- the protective effect of these amylase preparations was compared with that of human whole saliva proteins, human parotid saliva proteins and bovine colostrum proteins.
- Human parotid saliva proteins were obtained and tested as described in Example 3 and human whole saliva proteins as described in Example 2.
- Bovine colostrum proteins were derived from raw milk obtained from cows within 12 hours of having calved. Excess fat was removed from the colostrum by ether extraction, where after the de-fatted colostrum was dialysed and lyophilised.
- Figure 4 shows the protective effect of human parotid saliva proteins, which is rich in ⁇ -amylase, human whole saliva proteins having a relatively lower ⁇ -amylase concentration than that of parotid saliva proteins, the industrially-produced ⁇ -amylase preparations, and bovine colostrum protein.
- the protection of enamel offered by industrial ⁇ -amylases was comparable to that of human whole saliva proteins at equal concentrations (0.5% w/v), which in one case was better than bovine colostrum, which has a protective effect against dental erosion.
- the concentration of saliva proteins (0.5% w/v) used in the assay is far above that found in human parotid saliva, which under in vivo conditions is lower than 0.5% (around 2 mg/mL).
- the concentration of ⁇ -amylase that may be present in toothpaste can be as high as 5.0% w/v. Therefore, a toothpaste containing ⁇ -amylase can be manufactured to protect teeth against an acid exposure which is better than relying on human saliva.
- Example 5 A comparison of the protective capacity of ⁇ -amylase in a dental composition substantially free of ionic detergents against acid-induced enamel softening of bovine enamel surfaces
- the effect of ⁇ -amylase in toothpaste was tested on a standard toothpaste, which was substantially free of anionic surfactant(s) (detergent), (endo)protease(s) and lipase(s), but comprising the non-ionic surfactant, Steareth-30.
- the fluoride concentration was 1100 ppm and the fluoride source was sodium fluoride.
- the ⁇ -amylase was the fungal derived ⁇ -amylase Fungamyl from Novo Nordisk, which was mixed with the toothpaste matrix to yield a concentration of 3.0% w/w in the toothpaste.
- Positive control compositions - Standard toothpaste comprising non-ionic surfactant, Steareth-30, and 1100 ppm of fluoride, but without ⁇ -amylase.
- Negative control composition - Standard toothpaste comprising non-ionic surfactant, Steareth-30, and 1100 ppm of fluoride, but without ⁇ -amylase.
- Standard toothpaste with anionic detergent (SLS) and without ⁇ -amylase was 1100 ppm and the fluoride source was sodium fluoride.
- the selected enamel surfaces were exposed to a coating of toothpaste slurry for 30 minutes.
- the toothpaste slurry used for coating was introduced onto the enamel surfaces in a dilution of 1 :4 w/w in Millipore water at room temperature. This concentration was comparable to the toothpaste slurries used for coating enamel in similar studies (Fowler et al., 2006).
- the three toothpaste slurries were tested by immersing the enamel surfaces in 10 ml_ of each toothpaste slurry in a glass vial together with magnet rotating in a propeller fashion. After immersion in toothpaste, each enamel surface was exposed to 2 L of acidic eroding fluid [as given in Materials and methods: 1.4] for 5 minutes under constant and fast stirring. This time period is chosen as 3-5 minutes has previously been shown to be the time it takes for the oral fluids to regain supersaturation following intake of an acidic drink (Bashir and Lagerl ⁇ f, 1996).
- Holbrook WP Relationship between dental erosion, soft drink consumption, and gastroesophageal reflux among Icelanders.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne un procédé thérapeutique de prévention et/ou d’inhibition de l’érosion dentaire chez un sujet mammifère, et la fourniture d’un produit de soin dentaire pour réaliser le procédé. Le produit de soin dentaire de l’invention comprend une enzyme dégradant l’amidon d’E. C. 3.2.1.1, ledit produit comprenant moins de 1 % en poids de surfactant ionique, et étant de préférence sensiblement dépourvu d’endoprotéase et/ou de lipase. Les propriétés du produit de soin dentaire permettent de prévenir et/ou d’inhiber l’érosion dentaire chez un sujet, qui résulte typiquement de l’exposition répétée des surfaces des dents du patient aux acides, pouvant provenir de l’alimentation, des boissons, ou du suc gastrique.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09806428A EP2341985A1 (fr) | 2008-08-12 | 2009-08-11 | Formulations dentaires destinées à la prévention de l'érosion dentaire |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8824308P | 2008-08-12 | 2008-08-12 | |
US61/088,243 | 2008-08-12 | ||
DKPA200801088 | 2008-08-12 | ||
DKPA200801088 | 2008-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010018167A1 true WO2010018167A1 (fr) | 2010-02-18 |
Family
ID=40344443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/060376 WO2010018167A1 (fr) | 2008-08-12 | 2009-08-11 | Formulations dentaires destinées à la prévention de l’érosion dentaire |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2341985A1 (fr) |
WO (1) | WO2010018167A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107252395A (zh) * | 2012-12-05 | 2017-10-17 | 高露洁-棕榄公司 | 含磷酸锌的组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066570A1 (fr) * | 2000-03-09 | 2001-09-13 | Doman Kim | Enzyme d'hydrolisation de la plaque dentaire, micro-organisme produisant celle-ci et composition comprenant l'enzyme |
US20020006385A1 (en) * | 1997-10-17 | 2002-01-17 | Novozymes A/S | Plaque-inhibiting oral compositions |
WO2003018790A1 (fr) * | 2001-08-25 | 2003-03-06 | Lifenza Co., Ltd. | Enzyme possedant une activite d'elimination de plaque, sequence d'adn codant pour cette enzyme, cellule hote d'expression et procedes de production et de purification de l'enzyme |
WO2007085428A2 (fr) * | 2006-01-28 | 2007-08-02 | Henkel Ag & Co. Kgaa | Agent renfermant des enzymes pour l'hygiène buccale et dentaire et pour le brossage des dents et bain de bouche |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH541967A (de) * | 1967-06-30 | 1973-09-30 | Pacific Biochemical Inc | Gemisch zur Mundpflege und Verfahren zur Herstellung dieses Gemisches |
FR2860154B1 (fr) * | 2003-09-29 | 2006-02-03 | Chris Cardon | Composition pour le traitement de la mauvaise haleine |
-
2009
- 2009-08-11 EP EP09806428A patent/EP2341985A1/fr not_active Withdrawn
- 2009-08-11 WO PCT/EP2009/060376 patent/WO2010018167A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020006385A1 (en) * | 1997-10-17 | 2002-01-17 | Novozymes A/S | Plaque-inhibiting oral compositions |
WO2001066570A1 (fr) * | 2000-03-09 | 2001-09-13 | Doman Kim | Enzyme d'hydrolisation de la plaque dentaire, micro-organisme produisant celle-ci et composition comprenant l'enzyme |
WO2003018790A1 (fr) * | 2001-08-25 | 2003-03-06 | Lifenza Co., Ltd. | Enzyme possedant une activite d'elimination de plaque, sequence d'adn codant pour cette enzyme, cellule hote d'expression et procedes de production et de purification de l'enzyme |
WO2007085428A2 (fr) * | 2006-01-28 | 2007-08-02 | Henkel Ag & Co. Kgaa | Agent renfermant des enzymes pour l'hygiène buccale et dentaire et pour le brossage des dents et bain de bouche |
Non-Patent Citations (2)
Title |
---|
See also references of EP2341985A1 * |
UDUPA S L ET AL: "ALPHA AMYLASE INHIBITORS IN FOODSTUFFS", FOOD CHEMISTRY, vol. 34, no. 2, 1989, pages 95 - 102, XP002515761, ISSN: 0308-8146 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107252395A (zh) * | 2012-12-05 | 2017-10-17 | 高露洁-棕榄公司 | 含磷酸锌的组合物 |
CN107252395B (zh) * | 2012-12-05 | 2021-02-23 | 高露洁-棕榄公司 | 含磷酸锌的组合物 |
Also Published As
Publication number | Publication date |
---|---|
EP2341985A1 (fr) | 2011-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1888014B1 (fr) | Mineralisation dentaire | |
Imfeld | Prevention of progression of dental erosion by professional and individual prophylactic measures | |
Oshiro et al. | Effect of CPP-ACP paste on tooth mineralization: an FE-SEM study | |
Lennon et al. | Effect of a casein/calcium phosphate-containing tooth cream and fluoride on enamel erosion in vitro | |
RU2431464C2 (ru) | Композиция средства для чистки зубов, не содержащая алкилсульфата и ортофосфата, содержащая источник фторида и абразив для зубов на основе диоксида кремния | |
KR102221531B1 (ko) | 치아 광화를 위한 조성물 및 방법 | |
Dadamio et al. | The role of toothpastes in oral malodor management. | |
KR102696078B1 (ko) | 치은염을 위한 치료 | |
JP7053542B2 (ja) | スフィンゴシン系化合物による材料の保護 | |
EP1895996B1 (fr) | Preparation pour le traitement des maladies de la cavite buccale | |
EP2341985A1 (fr) | Formulations dentaires destinées à la prévention de l'érosion dentaire | |
Anbarani et al. | A Double-Blinded, Randomized Study Evaluating the In Vivo Effects of a Novel Dental Gel on Enamel Surface Microstructure and Microhardness. | |
JPWO2005000251A1 (ja) | 再石灰化促進剤、口腔用組成物 | |
KR0121564B1 (ko) | 치아 미백용 치약 조성물 | |
EA042241B1 (ru) | Лечение гингивита |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09806428 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009806428 Country of ref document: EP |